Academic literature on the topic 'Chetoacidosi'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Chetoacidosi.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Chetoacidosi"

1

Ventura, Alessandro. "la pagina gialla." Medico e Bambino 41, no. 1 (2022): 553–54. http://dx.doi.org/10.53126/meb41553.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Tagliani, Sara, Chiara Avventi, Silvia Ventresca, Sara Dal Bo, Vanna Graziani, and Federico Marchetti. "Chetoacidosi diabetica e urine scure: quale diagnosi?" Medico e Bambino pagine elettroniche 23, no. 10 (2020): 245–47. http://dx.doi.org/10.53126/mebxxiii245.

Full text
Abstract:
During the onset of diabetic ketoacidosis (DKA), the appearance of hyperchromic urines is a rare occurrence even if already described in the literature. The patient with DKA presents an increased risk to suffer of macrohaematuria due to nephrolithiasis (associated or not with urinary tract infections) and renal vein thrombosis. False macrohaematuria in rhabdomyolysis with myoglobinuria can also occur. This paper describes a case of an 11-year-old boy with severe onset of DKA, with macrohaematuria from kidney stones. The causes of nephrolithiasis in children with DKA are also reported.
APA, Harvard, Vancouver, ISO, and other styles
3

Falcetta, Pierpaolo, Francesco Saverio Indovina, Alberto Coppelli, Giuseppe Daniele, and Stefano Del Prato. "Inibitori di SGLT-2 e chetoacidosi euglicemica: conoscere per prevenire." L'Endocrinologo 20, no. 6 (2019): 336–40. http://dx.doi.org/10.1007/s40619-019-00646-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Uneddu, Antonio, and Tito Antonio Paolini. "Valutazione clinica e metabolica dell’impiego dell’insulina Lispro in pazienti con diabete mellito scompensato." Farmeconomia. Health economics and therapeutic pathways 6, no. 4 (2005): 397–400. http://dx.doi.org/10.7175/fe.v6i4.854.

Full text
Abstract:
The aim of the present work is to report preliminary results about the administration of an insulin analogue, LisPro, to treat diabetic chetoacidosis. This new procedure, in respect to insulin continuous infusion, allow significant cost reduction in terms of medical and nurses time dedicated to the patient and hospitalization length. In our experience, LisPro treatment compared to the standard of care, has allowed hospital time reduction of 2,1 days per patient. This can be translated in cost saving of about 700,00 euro per case. These preliminary data, replicating the results coming from publ
APA, Harvard, Vancouver, ISO, and other styles
5

Lera, R., V. Calcaterra, A. Secco, et al. "Caso clinico: grave dislipidemia trattata con plasmaferesi in un esordio di diabete di tipo 1 con chetoacidosi." Working Paper of Public Health 2, no. 1 (2013). http://dx.doi.org/10.4081/wpph.2013.6765.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Lera, R., V. Calcaterra, A. Secco, et al. "Caso clinico: grave dislipidemia trattata con plasmaferesi in un esordio di diabete di tipo 1 con chetoacidosi." October 17, 2016. https://doi.org/10.4081/wpph.2013.6765.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Uneddu, Antonio, and Tito Antonio Paolini. "Valutazione clinica e metabolica dell'impiego dell'insulina Lispro in pazienti con diabete mellito scompensato." June 13, 2016. https://doi.org/10.7175/fe.v6i4.854.

Full text
Abstract:
The aim of the present work is to report preliminary results about the administration of an insulin analogue, LisPro, to treat diabetic chetoacidosis. This new procedure, in respect to insulin continuous infusion, allow significant cost reduction in terms of medical and nurses time dedicated to the patient and hospitalization length. In our experience, LisPro treatment compared to the standard of care, has allowed hospital time reduction of 2,1 days per patient. This can be translated in cost saving of about 700,00 euro per case. These preliminary data, replicating the results coming from publ
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Chetoacidosi"

1

TORNESE, GIANLUCA. "Role of TRAIL (TNF-Related Apoptosis-Inducing Ligand) in the onset and progression of type 1 diabetes mellitus." Doctoral thesis, Università degli Studi di Trieste, 2016. http://hdl.handle.net/11368/2908001.

Full text
Abstract:
Experimental evidence in animal models suggests that TNF-related apoptosis-inducing ligand (TRAIL), a member of the TNF superfamily, might play an important role in type 1 diabetes (T1D). No studies had fully evaluated TRAIL levels in children affected by T1D. Study I – What happens to TRAIL levels in children with T1D? Retrospective study on 507 pediatric subjects consisting of patients diagnosed with T1D at onset (n = 167) or at later time points after diagnosis (n = 220), healthy individuals (n = 98, considered as controls), and healthy subjects positive to autoantibodies against β-cell
APA, Harvard, Vancouver, ISO, and other styles
2

Malerba, Eleonora Glenda Maria <1985&gt. "Chetoacidosi diabetica nel cane e nel gatto: nuove prospettive terapeutiche e strumenti di monitoraggio." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2019. http://amsdottorato.unibo.it/8861/1/Tesi%20di%20dottorato%20EM.pdf.

Full text
Abstract:
Complications induced by treatment of diabetic ketoacidosis (DKA) usually result from overly aggressive therapy, inadequate animal monitoring, and failure to reevaluate biochemical parameters in a timely manner. The thesis is divided into 6 studies focusing on new therapeutic and monitoring approaches during DKA treatment. Chapter 2 is an introduction to the topic and summarizes the current state of the art on DKA. Chapter 3 reports a study aimed at investigating the efficacy and safety of intravenous infusion of Lispro insulin in cats demonstrating that its use is associated with few side e
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!